Literature DB >> 16850442

Extracorporeal membrane oxygenation to rescue profound pulmonary hemorrhage due to idiopathic pulmonary hemosiderosis in a child.

Li-Chuan Sun1, Yu-Ru Tseng, Shu-Chien Huang, Pei-Ming Huang, Wen-Je Ko, Frank Leigh Lu, En-Ting Wu.   

Abstract

Idiopathic pulmonary hemosiderosis (IPH) is a rare cause of diffuse alveolar hemorrhage (DAH) in pediatric patients. During the acute phase, death due to massive alveolar hemorrhage and subsequent severe respiratory failure with associated multiple organ failure often occurs. We report the case of an 11-year-old girl who developed severe hypoxemic respiratory failure and pulmonary hemorrhage. Extracorporeal membrane oxygenation (ECMO) was instituted on the next day because medical treatment and mechanical ventilation failed to maintain oxygenation. She was successfully decannulated 5 days later without ECMO-related complications. Four months later, she was intubated again and the diagnosis of IPH was made by open lung biopsy. She was treated with systemic steroid therapy and discharged smoothly. We suggest that ECMO provides a chance of recovery and survival for patients with IPH, even if accompanied by severe pulmonary hemorrhage.

Entities:  

Mesh:

Year:  2006        PMID: 16850442     DOI: 10.1002/ppul.20460

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

1.  Extracorporeal Membrane Oxygenation for Diffuse Alveolar Hemorrhage Caused by Idiopathic Pulmonary Hemosiderosis: A Case Report and a Review of the Literature.

Authors:  Shotaro Matsumoto; Satoshi Nakagawa
Journal:  J Pediatr Intensive Care       Date:  2019-02-25

2.  Predictors of outcome for children requiring respiratory extra-corporeal life support: implications for inclusion and exclusion criteria.

Authors:  Nazima Pathan; Deborah A Ridout; Elizabeth Smith; Allan P Goldman; Katherine L Brown
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

Review 3.  Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions.

Authors:  Biplab K Saha; Nils T Milman
Journal:  Clin Rheumatol       Date:  2020-11-12       Impact factor: 3.650

4.  Severe Respiratory Distress in a Child with Pulmonary Idiopathic Hemosiderosis Initially Presenting with Iron-Deficiency Anemia.

Authors:  A Potalivo; L Finessi; F Facondini; A Lupo; C Andreoni; G Giuliani; C Cavicchi
Journal:  Case Rep Pulmonol       Date:  2015-11-08

5.  Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis.

Authors:  Wolfgang Hohenforst-Schmidt; Arndt Petermann; Aikaterini Visouli; Paul Zarogoulidis; Kaid Darwiche; Ioanna Kougioumtzi; Kosmas Tsakiridis; Nikolaos Machairiotis; Markus Ketteler; Konstantinos Zarogoulidis; Johannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2013-07-24       Impact factor: 4.162

6.  Clinical characteristics and prognosis of idiopathic pulmonary hemosiderosis in pediatric patients.

Authors:  Yajun Zhang; Fenglan Luo; Nini Wang; Yue Song; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-10-02       Impact factor: 1.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.